Down More Than 75% This Year, Should Investors Throw in the Towel on Iovance Biotherapeutics Stock?
21/5 03:10
Entering trading this week, shares of Iovance Biotherapeutics (NASDAQ: IOVA) have crashed by nearly 78% since the start of the year. It has been an abysmal start to 2025 for a company that does possess some attractive long-term growth prospects....